Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: Results from a 12-month, real-world study

Journal of Clinical Psychopharmacology

Volumn 32, Issue 4, 2012, Pages 458-464

  Zhang, Jian Ping ^a   Weiss, Jeffrey J ^b   McCardle, Melissa ^c   Klopchin, Hope ^d   Rosendahl, Eileen ^d   Maayan, Lawrence ^e,f   Convit, Antonio ^e,f   Kane, John M ^g,h   Manu, Peter ^g   Correll, Christoph U ^g,h  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MOLLOY COLLEGE   (United States)

^d LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^e Nathan Kline Institute for Psychiatric Research   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Attrition; Obesity; Psychosis; Weight loss; Weight management program

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; COGNITIVE BEHAVIORAL WEIGHT LOSS INTERVENTION; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBESITY; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

BODY MASS INDEX; BODY WEIGHT; COGNITIVE THERAPY; HUMANS; MENTAL DISORDERS; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, GROUP; PSYCHOTIC DISORDERS;

EID: 84863723803     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31825cccd2     Document Type: Article

References (30)

1. Sacks FM. Metabolic syndrome: epidemiology and consequences. J Clin Psychiatry. 2004;65(suppl 18):3-12.
2. Flegal KM, Graubard BI, Williamson DF, et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298(17):2028-2037. (Pubitemid 350074800)
3. De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52-77.
4. Correll CU, Lencz T, Malhotra AK. Antipsychotic drugs and obesity. Trends Mol Med. 2011;17(2):97-107.
5. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(suppl 1):1-93. (Pubitemid 40677047)
6. Correll CU, Sheridan EM, DelBello MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord. 2010;12(2):116-141.
7. Maayan L, Vakhrusheva J, Correll CU. Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis. Neuropsychopharmacology. 2010;35(7):1520-1530.
8. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Schizophr Bull. 2007;33(3):654-656. (Pubitemid 47343724)
9. Maayan L, Correll CU. Management of antipsychotic-related weight gain. Expert Rev Neurother. 2010;10(7):1175-1200.
10. Faulkner G, Cohn TA. Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications. Can J Psychiatry. 2006;51(8):502-511. (Pubitemid 44166338)
11. Shaw K, O'Rourke P, Del Mar C, et al. Psychological interventions for overweight or obesity. Cochrane Database Syst Rev. 2005;(2): CD003818.
12. Seo DC, Sa J. A meta-analysis of psycho-behavioral obesity interventions among US multiethnic and minority adults. Prev Med. 2008;47(6):573-582.
13. De Panfilis C, Torre M, Cero S, et al. Personality and attrition from behavioral weight-loss treatment for obesity. Gen Hosp Psychiatry. 2008;30(6):515-520.
14. Teixeira PJ, Going SB, Sardinha LB, et al. A review of psychosocial pre-treatment predictors of weight control. Obes Rev. 2005;6(1): 43-65.
15. Linde JA, Jeffery RW, Levy RL, et al. Binge eating disorder, weight control self-efficacy, and depression in overweight men and women. Int J Obes Relat Metab Disord. 2004;28(3):418-425. (Pubitemid 38296956)
16. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
17. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scaleYpreliminary report. Psychopharmacol Bull. 1973;9(1): 13-28.
18. Diener E, Emmons RA, Larsen RJ, et al. The Satisfaction With Life Scale. J Pers Assess. 1985;49(1):71-75. (Pubitemid 15080385)
19. Conte HR, Plutchik R, Karasu TB, et al. A self-report Borderline Scale. Discriminative validity and preliminary norms. J Nerv Mental Dis. 1980;168(7):428-435. (Pubitemid 10070154)
20. Beliard D, Kirschenbaum DS, Fitzgibbon ML. Evaluation of an intensive weight control program using a priori criteria to determine outcome. Int J Obes Relat Metab Disord. 1992;16(7):505-517.
21. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
22. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-1182.
23. Alvarez-Jimenez M, Hetrick SE, Gonzalez-Blanch C, et al. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2008;193(2):101-107.
24. Brar JS, Ganguli R, Pandina G, et al. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005;66(2):205-212. (Pubitemid 40314327)
25. Alvarez-Jimenez M, Gonzalez-Blanch C, Vazquez-Barquero JL, et al. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial. J Clin Psychiatry. 2006;67(8):1253-1260. (Pubitemid 44439698)
26. Menza M, Vreeland B, Minsky S, et al. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry. 2004; 65(4):471-477.
27. Wu MK, Wang CK, Bai YM, et al. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv. 2007;58(4):544-550.
28. Correll CU. Balancing efficacy and safety in treatment with antipsychotics. CNS Spectr. 2007;12(10 suppl 17):12-20.
29. Holt RI, Pendlebury J, Wildgust HJ, et al. Intentional weight loss in overweight and obese patients with severe mental illness: 8-year experience of a behavioral treatment program. J Clin Psychiatry. 2010;71(6):800-805.
30. Dalle Grave R, Calugi S, Molinari E, et al. Weight loss expectations in obese patients and treatment attrition: an observational multicenter study. Obes Res. 2005;13(11):1961-1969.